leezsnow/iStock Unreleased via Getty Images Krispy Kreme, Inc. (NASDAQ:DNUT), the well-recognized donut producer, is continuing on the company's strategic expansion path to 100 thousand access points with geographical expansion and the rollout with McDonalds (MCD) in the United States. The company's recently reported Q2 results came in nearly in line with expectations, continuing the long-term growth story well ahead of accelerated incoming growth. In my previous article, "Krispy Kreme Partners With McDonal ...

Have you assessed how the international operations of Krispy Kreme (DNUT) performed in the quarter ended June 2024? For this doughnut wholesaler and retailer, possessing an expansive global footprint, parsing the trends of international revenues could be critical to gauge its financial resilience and growth prospects. In the current global economy, which is more interconnected than ever, a company's success in penetrating international markets is crucial for its financial health and growth journey. Investor ...

Table of Contents Title of each class Trading Symbol Name of each exchange on which registered Common stock, $0.01 par value per share DNUT Nasdaq Global Select Market UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________ FORM 10-Q _________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECUR ...

Krispy Kreme, Inc. (NASDAQ:DNUT) Q2 2024 Earnings Conference Call August 8, 2024 8:30 AM ET Company Participants Josh Charlesworth - President & CEO Jeremiah Ashukian - CFO Conference Call Participants Sara Senatore - Bank of America Merrill Lynch Rahul Krotthapalli - JPMorgan Bill Chappell - Truist Securities Dan Guglielmo - Capital One Securities Operator [Abrupt Start] https://investors.krispykreme.com./ joining me on the call this morning are President and Chief Executive Officer Josh Charlesworth and C ...

Krispy Kreme (DNUT) reported $438.81 million in revenue for the quarter ended June 2024, representing a year-over-year increase of 7.3%. EPS of $0.05 for the same period compares to $0.07 a year ago. The reported revenue represents a surprise of +0.64% over the Zacks Consensus Estimate of $436.03 million. With the consensus EPS estimate being $0.05, the company has not delivered EPS surprise. While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expecta ...

Krispy Kreme (DNUT) came out with quarterly earnings of $0.05 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.07 per share a year ago. These figures are adjusted for non-recurring items. A quarter ago, it was expected that this doughnut wholesaler and retailer would post earnings of $0.07 per share when it actually produced earnings of $0.07, delivering no surprise. Over the last four quarters, the company has not been able to surpass consensus EPS estimates. Krispy Kre ...

EXHIBIT 99.1 Krispy Kreme reports second quarter 2024 financial results Second quarter Net Revenue grows 7.3%, Organic Revenue increases 7.8% Updated 2024 guidance reflects sale of majority stake in Insomnia Cookies CHARLOTTE, NC (August 8, 2024) – Krispy Kreme, Inc. (NASDAQ: DNUT) ("Krispy Kreme", "KKI", or the "Company") today reported financial results for the quarter ended June 30, 2024. Second Quarter Highlights (vs Q2 2023) • Net revenue grew 7.3% to $438.8 million • Organic revenue grew 7.8% to $440. ...

Analysts on Wall Street project that Krispy Kreme (DNUT) will announce quarterly earnings of $0.05 per share in its forthcoming report, representing a decline of 28.6% year over year. Revenues are projected to reach $436.84 million, increasing 6.8% from the same quarter last year. The consensus EPS estimate for the quarter has been revised 150% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this ...

Krispy Kreme Inc DNUT faces a sticky situation as it launches four new "F.R.I.E.N.D.S"-themed doughnuts, tantalizingly named after iconic show moments, like "WE WERE ON A COFFEE BREAK" and "HOW YOU DOIN'?". The twist? These treats are exclusively available in the UK, leaving American fans feeling glazed and confused. Krispy Kreme's decision to launch these doughnuts only in the UK comes amid a challenging period for the company's stock, which is down 15.97% over the past year and is 21.54% lower year-to-dat ...

While the demand for weight loss drugs continues to surge, one Wall Street firm is betting that Americans' love for doughnuts is too strong to give them up. HIMS & HERS ROLLS OUT WEIGHT-LOSS SHOTS MUCH CHEAPER THAN OZEMPIC, WEGOVY GLP-1 agonists are a class of Type 2 diabetes drugs that improves blood sugar control but may also lead to weight loss. Semaglutide, which is the active ingredient in Novo Nordisk's Wegovy and Ozempic, as well as tirzepatide, which is the active ingredient in Eli Lily's Mounjaro a ...